Telogen Effluvium Caused by COVID-19 in Elmhurst, New York: Report of a Cohort and Review

    December 2021 in “ Dermatology Online Journal
    Diana Gruenstein, Melissa O'Mara, Samantha Hussain PA, J. Levitt, Stacy Li PA, Jack Tom, Marie Léger
    Image of study
    TLDR COVID-19 has increased hair loss, but many patients see regrowth within months.
    The study "Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review" conducted a retrospective chart review of 66 patients who had COVID-19 infection and experienced either non-scarring hair loss or Telogen effluvium (TE). The study found that the prevalence of TE has increased during the COVID-19 pandemic. The clinical characteristics of patients with COVID-19-related TE were similar to other forms of TE, with many patients experiencing hair regrowth within several months.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 419 results

      community I’ve read multiple times that Fin increases hair quality… NOT for me!

      in Treatment  97 upvotes 1 year ago
      A user has been on finasteride for 6 months and feels their hair quality has worsened, experiencing more hair loss and scalp irritation. They are considering seeing a dermatologist, while others suggest the issue might be unrelated to finasteride, possibly due to deficiencies or other conditions.

      community C’est terrible - at my wits end

      in Female  449 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    6 / 1000+ results